vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $38.3M, roughly 1.5× ImmunityBio, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -161.8%, a 149.3% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 131.8%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-71.3M).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CBAT vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $38.3M |
| Net Profit | $-7.4M | $-61.9M |
| Gross Margin | 7.3% | 99.0% |
| Operating Margin | -13.6% | -169.0% |
| Net Margin | -12.5% | -161.8% |
| Revenue YoY | 131.8% | 407.0% |
| Net Profit YoY | -63.6% | -4.7% |
| EPS (diluted) | $-0.08 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $38.3M | ||
| Q3 25 | $60.9M | $32.1M | ||
| Q2 25 | $40.5M | $26.4M | ||
| Q1 25 | $34.9M | $16.5M | ||
| Q4 24 | $25.4M | $7.6M | ||
| Q3 24 | $44.6M | $6.1M | ||
| Q2 24 | $47.8M | — | ||
| Q1 24 | $58.8M | — |
| Q4 25 | $-7.4M | $-61.9M | ||
| Q3 25 | $2.7M | $-67.3M | ||
| Q2 25 | $-3.1M | $-92.6M | ||
| Q1 25 | $-1.6M | $-129.6M | ||
| Q4 24 | $-4.5M | $-59.2M | ||
| Q3 24 | $17.6K | $-85.7M | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $9.8M | — |
| Q4 25 | 7.3% | 99.0% | ||
| Q3 25 | 8.0% | 99.4% | ||
| Q2 25 | 11.0% | 99.5% | ||
| Q1 25 | 13.7% | 99.6% | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 26.6% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -13.6% | -169.0% | ||
| Q3 25 | -6.6% | -173.5% | ||
| Q2 25 | -8.7% | -269.8% | ||
| Q1 25 | -8.2% | -390.1% | ||
| Q4 24 | -26.0% | -919.0% | ||
| Q3 24 | -1.9% | -1314.3% | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 17.4% | — |
| Q4 25 | -12.5% | -161.8% | ||
| Q3 25 | 4.4% | -209.8% | ||
| Q2 25 | -7.6% | -350.3% | ||
| Q1 25 | -4.5% | -784.9% | ||
| Q4 24 | -17.8% | -783.4% | ||
| Q3 24 | 0.0% | -1404.0% | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | 16.7% | — |
| Q4 25 | $-0.08 | $-0.06 | ||
| Q3 25 | $0.03 | $-0.07 | ||
| Q2 25 | $-0.03 | $-0.10 | ||
| Q1 25 | $-0.02 | $-0.15 | ||
| Q4 24 | $-0.05 | $-0.08 | ||
| Q3 24 | $0.00 | $-0.14 | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $242.8M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $-500.5M |
| Total Assets | $426.2M | $501.9M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $242.8M | ||
| Q3 25 | $10.5M | $257.8M | ||
| Q2 25 | $45.7M | $153.7M | ||
| Q1 25 | $9.6M | $61.6M | ||
| Q4 24 | $11.0M | $149.8M | ||
| Q3 24 | $24.2M | $130.4M | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $23.8M | — |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $-500.5M | ||
| Q3 25 | $121.4M | $-524.3M | ||
| Q2 25 | $118.2M | $-570.7M | ||
| Q1 25 | $120.8M | $-591.4M | ||
| Q4 24 | $121.7M | $-489.1M | ||
| Q3 24 | $131.2M | $-745.1M | ||
| Q2 24 | $126.6M | — | ||
| Q1 24 | $120.9M | — |
| Q4 25 | $426.2M | $501.9M | ||
| Q3 25 | $363.9M | $519.0M | ||
| Q2 25 | $333.1M | $402.1M | ||
| Q1 25 | $311.5M | $303.8M | ||
| Q4 24 | $302.2M | $382.9M | ||
| Q3 24 | $293.5M | $364.6M | ||
| Q2 24 | $279.6M | — | ||
| Q1 24 | $286.5M | — |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $-70.4M |
| Free Cash FlowOCF − Capex | $16.1M | $-71.3M |
| FCF MarginFCF / Revenue | 27.3% | -186.2% |
| Capex IntensityCapex / Revenue | 23.4% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $-70.4M | ||
| Q3 25 | $14.6M | $-68.9M | ||
| Q2 25 | $13.8M | $-79.7M | ||
| Q1 25 | $-9.6M | $-85.9M | ||
| Q4 24 | $9.6M | $-85.1M | ||
| Q3 24 | $19.7M | $-98.8M | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $7.4M | — |
| Q4 25 | $16.1M | $-71.3M | ||
| Q3 25 | $6.0M | $-69.6M | ||
| Q2 25 | $4.1M | $-80.8M | ||
| Q1 25 | $-22.3M | $-87.0M | ||
| Q4 24 | $3.9M | $-87.3M | ||
| Q3 24 | $16.5M | $-101.6M | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $-454.0K | — |
| Q4 25 | 27.3% | -186.2% | ||
| Q3 25 | 9.9% | -217.2% | ||
| Q2 25 | 10.2% | -305.9% | ||
| Q1 25 | -63.9% | -526.9% | ||
| Q4 24 | 15.5% | -1155.4% | ||
| Q3 24 | 37.1% | -1663.2% | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | -0.8% | — |
| Q4 25 | 23.4% | 2.4% | ||
| Q3 25 | 14.1% | 2.3% | ||
| Q2 25 | 23.8% | 4.1% | ||
| Q1 25 | 36.3% | 6.8% | ||
| Q4 24 | 22.5% | 28.0% | ||
| Q3 24 | 7.0% | 45.7% | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 13.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
IBRX
Segment breakdown not available.
